Trial reportJournal of medical Internet research2025
The Effectiveness of a Chatbot Single-Session Intervention for People on Waitlists for Eating Disorder Treatment: Randomized Controlled Trial.
Trial report in Journal of medical Internet research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Usability and User Experience Assessment of Health Care Conversational Agents Using Validated Subjective Instruments: Systematic Review and Comparative Analysis.JMIR human factors · 2026Pooled it
- Body Image and Eating Disorder Education Chatbot, JEM, in Australia and Canada: First 6-Month Real-World Survey Evaluation.JMIR human factors · 2026Article
- The Digital Mirror: Clinical Potentials and Relational Risks of Generative AI in Mental Health Interventions.Current psychiatry reports · 2026Review
- Design, Development, and Validation of a Chatbot to Support Health Care Professionals Experiencing Workplace Aggression: Protocol for a Mixed Methods Study.JMIR research protocols · 2026Article
- Artificial Intelligence in Anorexia Nervosa Care: Comparing ChatGPT and Google Gemini.Nutrients · 2026Article
- Systematic review and meta analysis of chatbots in the management of depressive and anxiety symptoms.NPJ digital medicine · 2026Article
- The role of AI companions in supporting adaptive emotion regulation among university students with social anxiety.Discover mental health · 2026Article
- Artificial Intelligence in Eating Disorder Treatment: A Qualitative Analysis of Clinical Opportunities, Barriers, and Ethical Considerations From Multi-Disciplinary Focus Groups.The International journal of eating disorders · 2026Article
- Article
- "You Say Cognitive, I Say Cognitive": Can Misinformation-Informed Interventions Help Reduce Risk for Disordered Eating in Youth?The International journal of eating disorders · 2026Article
- Review
- The Use of Artificial Intelligence for Personalized Treatment in Psychiatry.Current psychiatry reports · 2025Review
- Barriers and facilitators to treatment in severe and enduring eating disorders: a mixed-methods study of access, engagement, and lived experience.Journal of eating disorders · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundEarly treatment is critical for improving eating disorder prognosis. Single-session interventions (SSIs) can provide short-term support to people on waitlists for eating disorder treatment; however, it is not always possible to access SSIs. We co-designed and developed a rule-based chatbot called ED ESSI (Eating Disorder Electronic Single-Session Intervention), which delivered an SSI and demonstrated its acceptability and feasibility. However, the effectiveness of ED ESSI is yet to be investigated.
objectiveThis study aimed to investigate the effectiveness of an SSI delivered by ED ESSI. We examined the chatbot's impact on eating disorder pathology, psychosocial impairment, depression, anxiety, stress, and motivation for change or treatment in individuals aged ≥16 years on waitlists for treatment for all types of eating disorders.
methodsThis multicenter 2-armed randomized controlled trial included 60 people on waitlists for eating disorder treatment in the chatbot intervention group (n=30, 50%) or the control group (n=30, 50%). The ED ESSI chatbot guided participants through a 30-minute SSI of assessment and psychoeducation, while the control group received web-based information on the same core topics covered in the SSI. There were 4 time points: before intervention or baseline (time point 1 [T1]), after intervention within 72 hours of baseline (T2), 1 month after baseline (T3), and 3 months after baseline (T4). Eating disorder pathology (primary outcome) and psychosocial impairment, depression, anxiety, and stress (secondary outcomes) were measured at T1, T3, and T4, and motivation for change or treatment (secondary outcome) was measured at all 4 time points. Furthermore, the System Usability Scale was implemented at T2 for the chatbot intervention group only.
resultsED ESSI induced significantly greater reductions compared to the control group in the primary outcome of eating disorder pathology (P=.003) and secondary outcomes of psychosocial impairment (P=.008), depression (P=.002), and anxiety (P=.040) over the 1- and 3-month time points, with small to moderate effects (Cohen d=0.15-0.53). Chatbot use also induced an increase in participants' confidence in their ability to change (secondary outcome) immediately after use (T2), with a moderate effect (P<.001; Cohen d=0.74). The chatbot was rated as "excellent" in terms of usability. A significantly higher proportion of participants in the chatbot group (28/30, 93%) entered treatment by 3 months upon the opportunity being offered to them, compared to the control group, with a moderate effect (21/30, 70%; P=.042; ϕ=0.30).
conclusionsED ESSI promptly induced improvements in eating disorder pathology, psychosocial impairment, depression, and anxiety, which were detectable at 1 month and maintained to 3 months. ED ESSI potentially represents an effective, accessible, and scalable form of early intervention for people aged ≥16 years waiting for eating disorder treatment. Further research is needed to determine the longer-term effectiveness of ED ESSI.
trial registrationAustralian New Zealand Clinical Trial Registry ACTRN12623000680662; https://tinyurl.com/2h9v7hh7.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.